Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
AAAS Promotion

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 7 August 1987:
Vol. 237. no. 4815, pp. 645 - 647
DOI: 10.1126/science.3110954

Articles

Science, Vol 237, Issue 4815, 645-647
Copyright © 1987 by American Association for the Advancement of Science


articles

Eosinophils cocultured with endothelial cells have increased survival and functional properties

ME Rothenberg, WF Owen Jr, DS Silberstein, RJ Soberman, KF Austen, and RL Stevens

Human peripheral blood eosinophils, cells often associated with allergic and parasitic diseases, were maintained in vitro for at least 14 days when they were cocultured with bovine endothelial cells and for at least 7 days when cultured with either bovine or human endothelial cell-derived conditioned medium. The cocultured eosinophils became hypodense and generated about three times as much leukotriene C4 upon activation with calcium ionophore and killed about three times as many antibody-coated larvae of Schistosoma mansoni as freshly isolated normodense eosinophils. That these cells can be maintained in vitro by coculture with endothelial cells, and the surprising finding that the cocultured eosinophils have biochemical, cytotoxic, and density properties similar to those of eosinophils in patients with allergic and other disorders, will facilitate investigation of the regulation and role of these cells in health and disease.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation.
H. H. Norris, M. E. Peterson, C. C. Stebbins, B. W. McConchie, V. G. Bundoc, S. Trivedi, M. G. Hodges, R. M. Anthony, J. F. Urban Jr, E. O. Long, et al. (2007)
J. Leukoc. Biol. 82, 1531-1541
   Abstract »    Full Text »    PDF »
Analysis of Eosinophil Turnover In Vivo Reveals Their Active Recruitment to and Prolonged Survival in the Peritoneal Cavity.
C. Ohnmacht, A. Pullner, N. van Rooijen, and D. Voehringer (2007)
J. Immunol. 179, 4766-4774
   Abstract »    Full Text »    PDF »
Activation of human eosinophils via P2 receptors: novel findings and future perspectives.
D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko (2006)
J. Leukoc. Biol. 79, 7-15
   Abstract »    Full Text »    PDF »
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist.
H.-U. Simon, M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer (2000)
J. Immunol. 165, 4069-4075
   Abstract »    Full Text »    PDF »
Syk-deficient eosinophils show normal interleukin-5-mediated differentiation, maturation, and survival but no longer respond to Fcgamma R activation.
E. Lach-Trifilieff, K. Menear, E. Schweighoffer, V. L. J. Tybulewicz, and C. Walker (2000)
Blood 96, 2506-2510
   Abstract »    Full Text »    PDF »
The Effect of Transendothelial Migration on Eosinophil Function.
H. Yamamoto, J. B. Sedgwick, R. F. Vrtis, and W. W. Busse (2000)
Am. J. Respir. Cell Mol. Biol. 23, 379-388
   Abstract »    Full Text »
Pharmacology of the Eosinophil.
M. A. Giembycz and M. A. Lindsay (1999)
Pharmacol. Rev. 51, 213-340
   Abstract »    Full Text »    PDF »
Eosinophilia.
M. E. Rothenberg (1998)
N. Engl. J. Med. 338, 1592-1600
   Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)